1. From the Kresge Eye Institute, the2Departments of Ophthalmology and
2. Section of Experimental Atherosclerosis, National Institutes of Health, Bethesda, Maryland;
3. Surgery, and the4Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan; the
4. Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan; the
5. Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; the
6. Department of Ophthalmology, Klinikum Hanau, Hanau, Germany; the
7. Departments of Human Genetics and
8. Ophthalmology, Saarland University, Homburg-Saar, Germany; the
9. Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; the
10. Department of Molecular Genetics, The Institute of Ophthalmology, University College London, London, United Kingdom; and
11. Transgenomic, Gaithersburg, Maryland.